Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 10—October 2024
Research

Economic Analysis of National Program for Hepatitis C Elimination, Israel, 20231

Yuval DadonComments to Author , Francis B. Mimouni, Ariella Toren, Tal Morgenstern, Lior Barak, and Joseph Mendlovic
Author affiliations: Ministry of Health, Jerusalem, Israel (Y. Dadon, A. Toren, T. Morgenstern, L. Barak, J. Mendlovic); Leumit Health Care, Tel Aviv, Israel (F.B. Mimouni); Sackler School of Medicine, Tel Aviv (F.B. Mimouni); Shaare Zedek Medical Center, Hadassah-Hebrew University School of Medicine, Jerusalem, Israel (J. Mendlovic)

Main Article

Table 2

Cost estimation per a resolved HCV case in an economic analysis of a national program for hepatitis C elimination, Israel, 2023*

Category
HCV antibody tested

Pending testing
Program total cost
No. patients
Cost per patient
Total cost
No. patients
Cost per patient
Total cost
Initial serology
555,083
23.5
13,044,451

308,826
23.5
7,257,411
20,301,862
PCR for positive serology
24,361
435.5
10,609,216

13,588†
435.5
5,917,724
16,526,939
Treatment







260,869,000‡
Posttreatment PCR for SVR
13,379
435.5
5,826,555

8,697§
435.5
3,787,544
9,614,099
No. SVR patients
12,911
NA
NA

8,392¶
NA
21,303

Total program cost







307,311,900
Cost per resolved HCV case 14,426 ($3,606)#

*A total of 863,909 persons were evaluated via serologic testing for HCV antibodies. Costs are in Israeli new shekel, except where indicated. HCV, hepatitis C virus; NA, not applicable; SVR, sustained viral response. †Given 4.4% positivity for HCV serology tested. ‡Overall treatment cost at Health Basket. §Given 64% positivity for HCV PCR testing. ¶Given 96.5% HCV resolution. #Conversion to US dollars based on 2012 data from ExchangeRates.org (https://www.exchangerates.org). Data should be inflation adjusted for accumulated inflation during 1999–2021.

Main Article

1Preliminary results from this study were presented at the Israel National Institute for Health Policy Research conference; May 31, 2023; Tel Aviv, Israel.

Page created: August 21, 2024
Page updated: September 17, 2024
Page reviewed: September 17, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external